BETRF
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
May 2 closing price
Capitalization
8.5M
BIXT
Price
$0.15
Change
-$0.00 (-0.00%)
Updated
May 2 closing price
Capitalization
13.61M
Ad is loading...

BETRF vs BIXT

Header iconBETRF vs BIXT Comparison
Open Charts BETRF vs BIXTBanner chart's image
BETTERLIFE PHARMA
Price$0.07
Change-$0.00 (-0.00%)
Volume$10K
Capitalization8.5M
Bioxytran
Price$0.15
Change-$0.00 (-0.00%)
Volume$15.16K
Capitalization13.61M
BETRF vs BIXT Comparison Chart
Loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BETRF vs. BIXT commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BETRF is a Hold and BIXT is a Hold.

Ad is loading...
COMPARISON
Comparison
May 05, 2025
Stock price -- (BETRF: $0.07 vs. BIXT: $0.15)
Brand notoriety: BETRF and BIXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BETRF: 89% vs. BIXT: 5%
Market capitalization -- BETRF: $8.5M vs. BIXT: $13.61M
BETRF [@Biotechnology] is valued at $8.5M. BIXT’s [@Biotechnology] market capitalization is $13.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BETRF’s FA Score shows that 0 FA rating(s) are green whileBIXT’s FA Score has 0 green FA rating(s).

  • BETRF’s FA Score: 0 green, 5 red.
  • BIXT’s FA Score: 0 green, 5 red.
According to our system of comparison, BETRF is a better buy in the long-term than BIXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIXT’s TA Score shows that 4 TA indicator(s) are bullish.

  • BIXT’s TA Score: 4 bullish, 3 bearish.

Price Growth

BETRF (@Biotechnology) experienced а +1.43% price change this week, while BIXT (@Biotechnology) price change was -5.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIXT($13.6M) has a higher market cap than BETRF($8.5M). BIXT YTD gains are higher at: 70.345 vs. BETRF (-1.423). BIXT has higher annual earnings (EBITDA): -2.67M vs. BETRF (-3.14M). BIXT has more cash in the bank: 34.7K vs. BETRF (18.7K). BIXT has less debt than BETRF: BIXT (934K) vs BETRF (1.24M). BETRF (0) and BIXT (0) have equivalent revenues.
BETRFBIXTBETRF / BIXT
Capitalization8.5M13.6M62%
EBITDA-3.14M-2.67M117%
Gain YTD-1.42370.345-2%
P/E RatioN/AN/A-
Revenue00-
Total Cash18.7K34.7K54%
Total Debt1.24M934K133%
FUNDAMENTALS RATINGS
BETRF vs BIXT: Fundamental Ratings
BETRF
BIXT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5737
P/E GROWTH RATING
1..100
41100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIXT's Valuation (85) in the null industry is in the same range as BETRF (100). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BIXT's Profit vs Risk Rating (100) in the null industry is in the same range as BETRF (100). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BIXT's SMR Rating (100) in the null industry is in the same range as BETRF (100). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BIXT's Price Growth Rating (37) in the null industry is in the same range as BETRF (57). This means that BIXT’s stock grew similarly to BETRF’s over the last 12 months.

BETRF's P/E Growth Rating (41) in the null industry is somewhat better than the same rating for BIXT (100). This means that BETRF’s stock grew somewhat faster than BIXT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIXT
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Advances
ODDS (%)
Bullish Trend 25 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
View a ticker or compare two or three
Ad is loading...
BIXT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMCPX30.620.65
+2.17%
Lord Abbett Mid Cap Stock P
FEEFX80.581.45
+1.83%
American Funds Fundamental Invs 529-F-3
ICEQX21.250.34
+1.63%
Macquarie Core Equity Fund Class R6
AABPX11.450.10
+0.88%
American Beacon Balanced Inv
INAAX16.630.08
+0.48%
ALPS/Kotak India ESG A

BETRF and

Correlation & Price change

A.I.dvisor tells us that BETRF and CLABF have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BETRF and CLABF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BETRF
1D Price
Change %
BETRF100%
+1.43%
CLABF - BETRF
20%
Poorly correlated
-10.28%
AVCTF - BETRF
15%
Poorly correlated
N/A
BSEM - BETRF
3%
Poorly correlated
+0.50%
BPMUF - BETRF
1%
Poorly correlated
N/A
BIXT - BETRF
1%
Poorly correlated
+2.09%
More

BIXT and

Correlation & Price change

A.I.dvisor tells us that BIXT and CCCC have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIXT and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIXT
1D Price
Change %
BIXT100%
+2.09%
CCCC - BIXT
22%
Poorly correlated
+6.75%
IMUX - BIXT
22%
Poorly correlated
-1.71%
WVE - BIXT
20%
Poorly correlated
+2.02%
DOMH - BIXT
20%
Poorly correlated
+10.98%
BSEM - BIXT
11%
Poorly correlated
+0.50%
More